Suppr超能文献

透明细胞肾细胞癌中的VHL恢复可改善自然杀伤细胞浸润和功能。

VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function.

作者信息

Tong Le, Tay Apple Hui Min, Cui Weiyingqi, Liu Yaxuan, Su Yanhong, Lyu Jiawen, Hoedemakers Leila, Yang Ying, Ehnman Monika, Seliger Barbara, Nordlund Par, Haglund de Flon Felix, Neo Shi Yong, Lundqvist Andreas

机构信息

Department of Oncology-Pathology, Karolinska Institutet, J6:20 BioClinicum, Akademiska straket 1, Solna, 17164, Stockholm, Sweden.

Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.

出版信息

Cancer Immunol Immunother. 2025 Jul 30;74(9):278. doi: 10.1007/s00262-025-04132-x.

Abstract

BACKGROUND

The von Hippel-Lindau (VHL) gene is frequently mutated in clear cell renal cell carcinoma (ccRCC) which results in stabilization of hypoxia-inducible factor (HIF). Despite the well-known immunosuppressive effect of HIF, ccRCC is considered an immunogenic tumor with high lymphocyte infiltration. Since NK cells have a prognostic value in ccRCC patients, it is important to understand how VHL mutations affect NK cell activity and anti-tumor immunity.

METHODS

Tumor spheroids were generated from parental 786-O (VHL-mutated) and 786-O-pVHL (VHL-restored) ccRCC cell lines. Tumor phenotypes, proteome, and secretome were analyzed by flow cytometry, mass spectrometry, and Luminex assays, respectively. Quantitative proteomics analysis and quantitative gene ontology enrichment were used to correlate protein expression changes to ccRCC progression and immunosuppressive pathways. NK cell infiltration, activation, and cytotoxicity were assessed in co-cultures of ccRCC spheroids with NK cells from healthy donors using real-time imaging, immunostaining, and flow cytometry, respectively.

RESULTS

VHL-mutated tumor spheroids were significantly less infiltrated by NK cells compared with VHL-restored tumor spheroids. pVHL-infiltrating NK cells showed an activated phenotype along with the ability to reduce tumor spheroid size. Proteomic analysis revealed that VHL-restored tumors express reduced levels of proteins associated with ccRCC progression and immunosuppression, including components of MHC class I processing and PD-1 signaling. Furthermore, VHL-restored tumors exhibited decreased levels of hypoxia-related and pro-tumoral cytokines, such as GROα, IL-8, IL-10, TRAIL, VEGF, and SCF. Within 768-O tumor spheroids, NK cells displayed a higher degree of hypoxia and expression of HIF1α, and inhibition of HIF1α resulted in higher NK cell infiltration into 786-O spheroids. Similarly, inhibition of the VHL-target gene, HIF2α, in 786-O spheroids resulted in increased NK cell infiltration.

CONCLUSIONS

VHL mutant tumors are less infiltrated by NK cells due to immunosuppressive pathways driven by HIF stabilization. Restoration of VHL reprograms the tumor microenvironment, reducing ccRCC progression and immunosuppressive signaling while enhancing NK cell infiltration and activation. Inhibition of HIFα improves NK cell infiltration into VHL mutant tumors. Therefore, inhibition of HIFα should be explored as a therapeutic strategy in ccRCC to improve NK cell anti-tumor efficacy against VHL-mutated tumors.

摘要

背景

在透明细胞肾细胞癌(ccRCC)中,冯·希佩尔-林道(VHL)基因经常发生突变,这会导致缺氧诱导因子(HIF)稳定。尽管HIF具有众所周知的免疫抑制作用,但ccRCC被认为是一种具有高淋巴细胞浸润的免疫原性肿瘤。由于自然杀伤(NK)细胞在ccRCC患者中具有预后价值,了解VHL突变如何影响NK细胞活性和抗肿瘤免疫非常重要。

方法

从亲本786 - O(VHL突变)和786 - O - pVHL(VHL恢复)ccRCC细胞系生成肿瘤球体。分别通过流式细胞术、质谱和Luminex分析来分析肿瘤表型、蛋白质组和分泌组。使用定量蛋白质组学分析和定量基因本体富集将蛋白质表达变化与ccRCC进展和免疫抑制途径相关联。分别使用实时成像、免疫染色和流式细胞术评估ccRCC球体与健康供体NK细胞共培养时的NK细胞浸润、激活和细胞毒性。

结果

与VHL恢复的肿瘤球体相比,VHL突变的肿瘤球体被NK细胞浸润的程度明显更低。浸润pVHL的NK细胞表现出激活的表型以及减小肿瘤球体大小的能力。蛋白质组分析显示,VHL恢复的肿瘤表达与ccRCC进展和免疫抑制相关的蛋白质水平降低,包括MHC I类加工和PD - 1信号通路的成分。此外,VHL恢复的肿瘤中缺氧相关和促肿瘤细胞因子的水平降低,如GROα、IL - 8、IL - 10、TRAIL、VEGF和SCF。在786 - O肿瘤球体中,NK细胞表现出更高程度的缺氧和HIF1α表达,抑制HIF1α导致更多NK细胞浸润到786 - O球体中。同样,在786 - O球体中抑制VHL靶向基因HIF2α导致NK细胞浸润增加。

结论

由于HIF稳定驱动的免疫抑制途径,VHL突变肿瘤被NK细胞浸润的程度较低。VHL的恢复可重新编程肿瘤微环境,减少ccRCC进展和免疫抑制信号,同时增强NK细胞浸润和激活。抑制HIFα可改善NK细胞浸润到VHL突变肿瘤中。因此,应探索抑制HIFα作为ccRCC的一种治疗策略,以提高NK细胞对VHL突变肿瘤的抗肿瘤疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e005/12311085/82b9e930c3ea/262_2025_4132_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验